Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Researchers at the University of Pennsylvania showed that in a form of canine blindness retinal cells continue to differentiate for a period of time early in a dog’s life before overwhelming cell death caused the retina to degenerate.
Researchers at LSU Health New Orleans have shown that a protein critical to the body’s ability to remove waste products from the brain and retina is diminished in age-related macular degeneration.
Researchers from the Harvard Medical School Department of Ophthalmology and the Schepens Eye Research Institute of Mass. Eye and Ear have gained new insight into how a noninflammatory state is maintained in the body.
A new study by at the University of Rochester shows that cells normally associated with protecting the brain from infection and injury also play an important role in rewiring the connections between nerve cells.
An NEI-funded researcher at the University of Kentucky College of Medicine discovered with an international team a previously unrecognized function for antibodies.
Columbia University Medical Center (CUMC) and University of Iowa scientists have used a new gene-editing technology called CRISPR to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition.
A new study from NYU enhances our understanding of the decision-making process, potentially offering insights into different forms of mental illness in which this dynamic is typically impaired.
A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinitis pigmentosa, a degenerative eye disease with no known cure that can lead to blindness.
Retinal implants that deliver longer pulses of electrical current may noticeably improve image sharpness for individuals who have lost their sight due to retinitis pigmentosa, according to a new study.